Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2025)
Corcept Therapeutics recorded quarterly Amortizatization of Intangibles of $4.6 million in Q4 2025, up 2322.87% quarter-over-quarter from $188000.0 in Q3 2025, and up 2444.69% year-over-year from $179000.0 in Q4 2024.
Corcept Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $4.6 million for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 2444.69% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $5.1 million (up 843.25% YoY), while the FY2025 annual figure was $5.1 million, up 843.25% from the prior year.
- Amortizatization of Intangibles came in at $4.6 million for Q4 2025 at Corcept Therapeutics, up from $188000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q4 2025 to a low of -$3.0 million in Q4 2022.
- A 5-year average of $378800.0 and a median of $185500.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 691.73% in 2022 and surged 2444.69% in 2025, its largest moves.
- Corcept Therapeutics' Amortizatization of Intangibles stood at $508000.0 in 2021, then plunged by 691.73% to -$3.0 million in 2022, then jumped by 101.93% to $58000.0 in 2023, then surged by 208.62% to $179000.0 in 2024, then soared by 2444.69% to $4.6 million in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $4.6 million, $188000.0, and $183000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.56 Mn |
| Dec 31, 2025 | 4.56 Mn |
| Sep 30, 2025 | 188,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 179,000.00 |
| Dec 31, 2024 | 179,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 57,000.00 |
| Sep 30, 2023 | 57,000.00 |
| Jun 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 119,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2022 | -3.01 Mn |
| Dec 31, 2022 | -3.01 Mn |
| Sep 30, 2022 | 557,000.00 |
| Sep 30, 2022 | 557,000.00 |
| Jun 30, 2022 | 552,000.00 |
| Jun 30, 2022 | 552,000.00 |
| Mar 31, 2022 | 514,000.00 |
| Mar 31, 2022 | 514,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Sep 30, 2021 | 502,000.00 |
| Sep 30, 2021 | 502,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Mar 31, 2021 | 489,000.00 |
| Mar 31, 2021 | 489,000.00 |
| Dec 31, 2020 | 484,000.00 |
| Dec 31, 2020 | 484,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Jun 30, 2020 | 385,000.00 |
| Jun 30, 2020 | 385,000.00 |
| Mar 31, 2020 | 364,000.00 |
| Mar 31, 2020 | 364,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 364,000.00 |
| Sep 30, 2019 | 364,000.00 |
| Jun 30, 2019 | 359,000.00 |
| Jun 30, 2019 | 359,000.00 |
| Mar 31, 2019 | 413,000.00 |
| Mar 31, 2019 | 413,000.00 |
| Dec 31, 2017 | 44,000.00 |
| Dec 31, 2017 | 44,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Sep 30, 2015 | 698,000.00 |
| Sep 30, 2015 | 698,000.00 |
| Jun 30, 2015 | 737,000.00 |
| Jun 30, 2015 | 737,000.00 |
| Mar 31, 2015 | 762,000.00 |
| Mar 31, 2015 | 762,000.00 |
| Dec 31, 2014 | 804,000.00 |
| Dec 31, 2014 | 804,000.00 |
| Sep 30, 2014 | 895,000.00 |
| Sep 30, 2014 | 895,000.00 |
| Jun 30, 2014 | 935,000.00 |
| Jun 30, 2014 | 935,000.00 |
| Mar 31, 2014 | 1.04 Mn |
| Mar 31, 2014 | 1.04 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Sep 30, 2013 | 1.10 Mn |
| Sep 30, 2013 | 1.10 Mn |
| Jun 30, 2013 | 1.10 Mn |
| Jun 30, 2013 | 1.10 Mn |
| Mar 31, 2013 | 1.12 Mn |
| Mar 31, 2013 | 1.12 Mn |
| Dec 31, 2012 | 1.11 Mn |
| Dec 31, 2012 | 1.11 Mn |